Novavax (NVAX) Misses Q1 EPS by 1c

May 9, 2018 4:38 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.14), $0.01 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $9.33 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities